title: In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
abstract: Ten isolates of the recently delineated genospecies Borrelia spielmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern of B. spielmanii mainly parallels that of the other known human-pathogenic members of the B. burgdorferi sensu lato complex.
authors.affiliation: Institute of Medical Microbiology and Infection Control, University Hospital of Frankfurt, Frankfurt, Main, Germany. Kristina.Morgenstern@vetmed.uni-giessen.de
authors.forename: Kristina
authors.initials: K
authors.lastname: Morgenstern
authors.forename: Georg
authors.initials: G
authors.lastname: Baljer
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Norris
authors.forename: Peter
authors.initials: P
authors.lastname: Kraiczy
authors.forename: Christa
authors.initials: C
authors.lastname: Hanssen-Hübner
authors.forename: Klaus-Peter
authors.initials: KP
authors.lastname: Hunfeld
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi / Q000235:genetics*; D015748:Borrelia burgdorferi Group / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D017408:Guidelines as Topic; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy* / Q000235:genetics; D008826:Microbial Sensitivity Tests; D013997:Time Factors
chemical_list: D000890:Anti-Infective Agents